SOLV

SOLVENTUM CORP

SOLV·83444M101·US·Common Stock·Healthcare - Medical Instruments & Supplies-13D/G

SOLV (SOLVENTUM CORP) is held by 263 institutional investors as of Q2 2026. Largest holders: Independent Franchise Partners LLP ($1.2B), BlackRock, Inc. ($753.1M), VANGUARD CAPITAL MANAGEMENT LLC ($742.6M). Net institutional sentiment: Mixed. In Q2 2026, 2 members of Congress and 126 funds bought SOLV.

263
Holders
(22 Elite)
$9B
Total Value
45% (283)
Consensus
126 buying - 157 selling
13F: Insider & Congress: Updated regularly
SOLV

Smart Money Verdict

View all
Loading verdict
Held by 263 funds
22 elite

Who's Trading

Source dates: Price Oct 14, 2026 · Insiders Sep 3, 2026 · Activists Apr 30, 2026 · Congress Aug 5, 2026

InsiderHCHanson Bryan CExercise 67K shSep 1, 2026
InsiderHCHanson Bryan CTax 26K shSep 1, 2026
InsiderHCHanson Bryan CTax 14K shMay 13, 2026
Checking access…

Top Holders

Checking access…
Action
Increased
16.2M(+2.8%)$1.2B8.2%+17.11%
65
Decreased
9.8M(-6.8%)$753.1M0.0%+30.93%
0
Increased
9.6M(+0.2%)$742.6M0.0%+23.20%
32
Unchanged
8.2M$635.5M15.0%+49.23%
0
Decreased
6.3M(-1.0%)$488.3M0.0%+23.23%
0
Decreased
6.3M(-0.4%)$486.7M2.1%+51.98%
0
Decreased
5.6M(-12.0%)$435.1M0.0%+60.00%
0
Increased
4.9M(+3.3%)$378.3M0.0%+24.72%
32
Increased
4M(+3.2%)$311.5M0.3%+22.36%
38
Decreased
3.3M(-12.7%)$255.4M0.0%+47.75%
0
Increased
2.1M(+11.2%)$160.4M0.0%+33.82%
34
Unchanged
2.1M$159.6M0.1%+65.02%
0
Decreased
1.9M(-19.6%)$150.1M1.2%+14.60%
0
Increased
1.8M(+134.6%)$140.2M0.0%+25.02%
49
Decreased
1.5M(-13.0%)$118.3M0.0%+48.88%
0
Increased
1.5M(+0.2%)$117.5M0.0%+49.87%
30
Decreased
1.4M(-9.9%)$107.1M0.0%+53.78%
0
Decreased
1.3M(-9.8%)$99.7M0.0%+32.63%
0
Increased
1.2M(+122.1%)$92.6M0.0%+14.71%
48
Increased
1.1M(+48.2%)$83.5M0.0%+22.83%
41

Showing 1-20 of 294

1 / 15
SOLVSOLVSOLVENTUM CORP

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used